{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T13:49:09Z","timestamp":1785678549405,"version":"3.56.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4911,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1038\/modpathol.2009.61","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T10:03:48Z","timestamp":1240567428000},"page":"1044-1048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma"],"prefix":"10.1016","volume":"22","author":[{"given":"Uma","family":"Krishnamurti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L","family":"Hammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folefac D","family":"Atem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D","family":"Storto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan F","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2009.61_bib1","first-page":"2019","article-title":"Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene","volume":"7","author":"van de Vijver","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1038\/modpathol.2009.61_bib2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0888-7543(89)90343-1","article-title":"Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32","volume":"4","author":"Popescu","year":"1989","journal-title":"Genomics"},{"key":"10.1038\/modpathol.2009.61_bib3","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1126\/science.3012781","article-title":"The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity","volume":"232","author":"Akiyama","year":"1986","journal-title":"Science"},{"key":"10.1038\/modpathol.2009.61_bib4","doi-asserted-by":"crossref","first-page":"8498","DOI":"10.1073\/pnas.84.23.8498","article-title":"Stage- and tissue-specific expression of the neu oncogene in rat development","volume":"84","author":"Kokai","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2009.61_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1038\/modpathol.2009.61_bib6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"10.1038\/modpathol.2009.61_bib7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1200\/JCO.1992.10.7.1049","article-title":"Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group","volume":"10","author":"Gusterson","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.61_bib8","first-page":"4960","article-title":"Her-2\/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease","volume":"53","author":"Press","year":"1993","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2009.61_bib9","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1200\/JCO.1998.16.4.1340","article-title":"neu\/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group","volume":"16","author":"Andrulis","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.61_bib10","first-page":"2825","article-title":"Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2\/neu overexpressing human breast cancer xenografts","volume":"58","author":"Baselga","year":"1998","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2009.61_bib11","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1200\/JCO.1999.17.9.2639","article-title":"Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease","volume":"17","author":"Cobleigh","year":"1999","journal-title":"J Clin Oncol"},{"issue":"6 Suppl 11","key":"10.1038\/modpathol.2009.61_bib12","first-page":"38","article-title":"Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer","volume":"27","author":"Fornier","year":"2000","journal-title":"Semin Oncol"},{"key":"10.1038\/modpathol.2009.61_bib13","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.ejca.2007.07.033","article-title":"HER2 status in early breast cancer: relevance of cell staining patterns, gene amplification and polysomy 17","volume":"43","author":"Torrisi","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2009.61_bib14","first-page":"1073","article-title":"Chromosomal aneusomy (chr 1, 11, 17) detected by fluorescence in situ hybridization may be a prognostic factor in breast cancer","volume":"27","author":"Takehisa","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1038\/modpathol.2009.61_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/jcp.2007.050336","article-title":"The effect of chromosome 17 polysomy on HER-2\/neu status in breast cancer","volume":"61","author":"Hyun","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2009.61_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/cncr.9024","article-title":"Clinicopathologic analysis of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridization","volume":"93","author":"Tsukamoto","year":"2001","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2009.61_bib17","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1158\/1535-7163.MCT-06-0129","article-title":"Correction for chromosome-17 is critical for the determination of true Her-2\/neu gene amplification status in breast cancer","volume":"5","author":"Dal Lago","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1038\/modpathol.2009.61_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1525-1578(10)60467-9","article-title":"Impact of polysomy 17 on HER-2\/neu immunohistochemistry in breast carcinomas without HER-2\/neu gene amplification","volume":"5","author":"Lal","year":"2003","journal-title":"J Mol Diagn"},{"key":"10.1038\/modpathol.2009.61_bib19","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1158\/1078-0432.CCR-04-2256","article-title":"Polysomy 17 in HER-2\/neu status elaboration in breast cancer: effect on daily practice","volume":"11","author":"Ma","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2009.61_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1021399923825","article-title":"Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma","volume":"77","author":"Watters","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1038\/modpathol.2009.61_bib21","first-page":"88","article-title":"[Clinicopathologic significance of chromosome 17 polysomy in breast cancer]","volume":"37","author":"Lu","year":"2008","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1038\/modpathol.2009.61_bib22","doi-asserted-by":"crossref","first-page":"R267","DOI":"10.1186\/bcr996","article-title":"Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry","volume":"7","author":"Salido","year":"2005","journal-title":"Breast Cancer Res"},{"key":"10.1038\/modpathol.2009.61_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/j.1460-2075.1987.tb04797.x","article-title":"Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms","volume":"6","author":"Kraus","year":"1987","journal-title":"EMBO J"},{"key":"10.1038\/modpathol.2009.61_bib24","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/01.pas.0000165528.78945.95","article-title":"The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study","volume":"29","author":"Downs-Kelly","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.61_bib25","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1200\/JCO.2007.13.4296","article-title":"Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing","volume":"26","author":"Vanden Bempt","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.61_bib26","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.96.19.10869","article-title":"The HER-2\/neu receptor tyrosine kinase gene encodes a secreted autoinhibitor","volume":"96","author":"Doherty","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2009.61_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/CCO.0b013e3282f0ad8e","article-title":"The complexity of genotypic alterations underlying HER2-positive breast cancer: an explanation for its clinical heterogeneity","volume":"19","author":"Vanden Bempt","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1038\/modpathol.2009.61_bib28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF02893497","article-title":"HER-2, TOP2A and chromosome 17 alterations in breast cancer","volume":"13","author":"Beser","year":"2007","journal-title":"Pathol Oncol Res"},{"key":"10.1038\/modpathol.2009.61_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/bcr541","article-title":"The role of the ubiquitination-proteasome pathway in breast cancer: ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer","volume":"5","author":"Lipkowitz","year":"2003","journal-title":"Breast Cancer Res"},{"key":"10.1038\/modpathol.2009.61_bib30","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1158\/0008-5472.CAN-06-3936","article-title":"Protein kinase Calpha determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplification","volume":"67","author":"Magnifico","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2009.61_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/jcp.2006.043562","article-title":"Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy","volume":"61","author":"Hofmann","year":"2008","journal-title":"J Clin Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol200961.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol200961","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol200961.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:00:45Z","timestamp":1760230845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222024887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0893395222024887"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2009.61","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor prognostic significance of unamplified chromosome 17 polysomy in invasive breast carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2009.61","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}